Tongling calls off the "problem injection" of deproteinized calf blood extract

Recently, Wuhan Hualong biopharmaceutical Co., Ltd failed to comply with the drug standards and violated the relevant laws and regulations to purchase intermediate products to produce calf blood deproteinized extract injection In response to "problem injection", Tongling food and Drug Administration recently carried out a special inspection in the whole city, calling for an emergency stop of "problem injection" It is reported that the State Food and Drug Administration issued a circular saying that it is preliminarily verified that Wuhan Hualong biopharmaceutical Co., Ltd did not purchase intermediate products to produce calf blood deproteinized extract injection in accordance with drug standards and in violation of relevant laws and regulations, and all relevant production records were forged All drug dealers and medical institutions are required to immediately stop selling and using the calf blood deproteinized extract injection produced by Wuhan Hualong biopharmaceutical Co., Ltd., and actively cooperate with the manufacturer to do a good job in drug recall Tongling food and drug administration immediately carried out a special inspection in the whole city, requiring all drug distributors and users to carry out self inspection Once the notified drugs are found, they must immediately stop selling and using, register and seal them up, and fill in the information of inventory products At the same time, cooperate with the recall work, and do a good job in patient interpretation to avoid drug market panic At present, no calf blood deproteinized extract injection produced by Wuhan Hualong biopharmaceutical Co., Ltd has been found in Tongling pharmaceutical enterprises and medical institutions.